上海麦角硫因生物科技集团有限公司致力于延缓生命衰老，专注于应用合成生物学技术生产天然的抗衰活性成分。
下属公司心氟科技成立于2016年，设立之初即为解决L-(+)-麦角硫因（右旋麦角硫因）化学生产中的D-(-)-麦角硫因杂质残留和植物提取法中的溶剂残留和不可再生资源限制问题。发展至今，公司已经具有一支求真务实的研发团队，并建立了由中科院研究员担任主席的科学顾问委员会。
我司专注于酶定向进化和高密度生物发酵技术，并在此方面具有世界领先优势。基于在酶定向进化、高密度发酵、高效酶催化、纯化转晶等方面的专利技术，2021年公司实现了全球***套规模化生物法生产麦角硫因装置的开车成功。产品纯度高达99%，旋光度≧+124°。
我司的麦角硫因 为无味的白色晶体，不吸湿、且无“有毒溶剂”和“D-麦角硫因”残留，品质大大优于国际市场同类产品，2022年荣获“荣格创新奖”、“CIC创新原料奖”等奖项，并获得国内外知名客户的广泛认可。
我司将持续专注于延缓衰老的研究，依托生物发酵和酶定向进化两大技术平台，精益求精，为食品、保健、化妆品和医药等行业提供更多有效的抗衰活性成分。
Shanghai EGT Synbio Group Co., Ltd. is committed to the mission of delaying aging, focusing on the application of synthetic biology technology to produce natural anti-aging active ingredients.
Its subsidiary, YG Ingredirnts, was established in 2016. At the beginning of its establishment, it was to solve the problems in L-(+)-ergothioneine production process, such as the impurity residue of D-(-)-ergothioneine during chemical production, the solvent residue and non-renewable resource limitations during plant extraction production. By now, we have established a truth-seeking and pragmatic R&D team, and also established a scientific advisory committee chaired by researchers from Chinese Academy of Sciences.
Our company focuses on the technologies of enzyme-directional evolution and high-density biological fermentation, and has earned leading advantages in these fields. Based on patent technologies of enzyme-directional evolution, high-density fermentation, high-efficiency enzyme catalysis, purification and trans-crystallization, we realized the facility startup of the world's *** large-scale biological process of producing ergothioneine. The purity of our ergothioneine is up to 99%, and the optical rotation is ≧+124°. Our ergothioneine is white crystal, odorless, and non-hygroscopic, and has no residues of "toxic solvent" and "D-ergothioneine". The quality is much better than our competitor’s products in international market. Our L-(+)-ergothioneine has won the prizes of "Ringer Innovation Award" and “CIC Innovative Raw Material Award’’ in 2022, and was widely recognized by well-known large customers at home and abroad.
Our company will continue to focus on anti-aging research. Relying on two major technology platforms of biological fermentation and enzyme-directional evolution, we will strive for continuous improvement and provide more and more effective anti-aging active ingredients for food, health care, cosmetics and pharmaceutical industries.